A Study of ALX148 With Azacitidine for Higher Risk Myelodysplastic Syndrome
Condition: Higher Risk Myelodysplastic Syndromes Interventions: Drug: ALX148; Drug: Azacitidine Sponsor: ALX Oncology Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials